Maintaining immunogenicity of blood stage and sexual stage subunit malaria vaccines when formulated in combination.
BACKGROUND:Eradication of Plasmodium falciparum malaria will likely require a multivalent vaccine, but the development of a highly efficacious subunit-based formulation has been challenging. We previously showed that production and immunogenicity of two leading vaccine targets, PfMSP119 (blood-stage...
Main Authors: | Elizabeth M Parzych, Kazutoyo Miura, Carole A Long, James M Burns |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0232355 |
Similar Items
-
Low immunogenicity of malaria pre‐erythrocytic stages can be overcome by vaccination
by: Katja Müller, et al.
Published: (2021-04-01) -
Assessment of the safety, immunogenicity and efficacy of novel blood-stage malaria vaccines
by: Payne, Ruth
Published: (2016) -
Toward improved blood-stage malaria vaccines : characterising the underlying immunogenicity of vaccine adjuvants and vectors
by: Cassan, Simone de
Published: (2011) -
A step forward for an attenuated blood-stage malaria vaccine
by: James M. Burns
Published: (2018-11-01) -
Immunogenicity and Efficacy Evaluation of Subunit Astrovirus Vaccines
by: Mehdi R.M. Bidokhti, et al.
Published: (2019-08-01)